As a direct continuation of scientific research on the study of the antianemic activity of tinctures prepared on the basis of the collection of medicinal plants, the activity of TCMP against anemia caused by the introduction of 25 ml/kg of phenylhydrazine hydrochloride under the skin of experimental animals was studied. At the same time, the digestibility of the studied tincture and the specific drug Coamide was evaluated by such indicators as the survival of animals, their general condition and activity of movements, as well as changes in the general blood test. Based on the studies conducted, it can be concluded that TCMP has a positive effect on hemolytic anemia, such as the drug coamide, which is widely used in medicine, but its effect on this anemia occurs at a level lower than that of the drug coamide. This means that the effect of the tincture on the course of hemolytic anemia was significantly slower than the antianemic results in other models of anemia. Although the studied drug has little activity in relation to the existing drug, it lays the foundation for large-scale scientific research on the preparation and introduction of biologically active additives based on it in the future, which allows it to be used with the main drugs in the treatment of various anemic diseases.